Ever Source Wealth Advisors, LLC Acadia Pharmaceuticals Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.25 Billion
- Q1 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 120 shares of ACAD stock, worth $1,935. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120
Previous 22
445.45%
Holding current value
$1,935
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ACAD
# of Institutions
299Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$691 Million10.04% of portfolio
-
Rtw Investments, LP New York, NY13.8MShares$223 Million4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$215 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$188 Million0.01% of portfolio
-
State Street Corp Boston, MA6MShares$96.8 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.61B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...